Metagenomi Therapeutics, Inc. Increase (Decrease) in Deferred Revenue
Metagenomi Therapeutics, Inc. (MGX) reported Increase (Decrease) in Deferred Revenue of -$491.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-10
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-06-30 was $257.00K.
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2026-03-31 was -$748.00K.
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-06-30 was -$7.37M.
- Metagenomi Therapeutics, Inc. increase (decrease) in deferred revenue for the quarter ending 2025-03-31 was -$3.05M.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 6 month |
|---|---|---|
| 2026-06-30 | $257.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$491.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | -$748.00K 10-Q · filed 2026-05-11 | |
| 2025-06-30 | -$7.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$10.42M 10-Q · filed 2026-08-10 |
| 2025-03-31 | -$3.05M 10-Q · filed 2026-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |